Eli Lilly, InSilico Strike AI Drug Discovery Deal
(feeds.content.dowjones.io)
61.
62.
63.
The Decadelong Feud Shaping the Future of AI
(feeds.content.dowjones.io)
65.
66.
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
(feeds.content.dowjones.io)
67.
Eye drops made from pig semen deliver cancer treatment to mice
(feeds.nature.com)
68.
Towards intelligent and miniaturized drug delivery devices
(feeds.nature.com)
69.
Roche Halts Development of Drug Candidate for Muscle Diseases, Chugai Says
(feeds.content.dowjones.io)
71.
72.
Drugwars for the TI-82/83/83 Calculators (2011)
(news.ycombinator.com)
73.
Drugwars for the TI-82/83/83 Calculators
(news.ycombinator.com)
74.
FDA approves higher-dose version of Wegovy shots
(feeds.feedburner.com)
75.
Daily briefing: Static electricity is still a mystery — here’s what we know
(feeds.nature.com)
76.
Strength persists after a mid-life course of obesity drugs
(feeds.nature.com)
77.
Botanical mystery solved: how plants make a crucial malaria drug
(feeds.nature.com)
78.
The American Healthcare Conundrum
(news.ycombinator.com)
79.
80.
81.
Why smaller portions are the biggest restaurant trend right now
(feeds.feedburner.com)
82.
‘Musclezempic’ Could Be the Future of Weight Loss
(gizmodo.com)
83.
85.
Modeling cycles of grift with evolutionary game theory
(news.ycombinator.com)
86.
Modeling Cycles of Grift with Evolutionary Game Theory
(news.ycombinator.com)
87.
88.
Are obesity drugs causing a severe complication? What the science says
(feeds.nature.com)
89.
Biologists marvel at new AI drug discovery tool – but details are hidden
(feeds.nature.com)
90.